Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens – Trademark Portfolio

Entity Type: 17

Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 1 filings in this category. The owner is based in Salem, OR.

3384 Augusta National Drive S.

Salem, OR 97302

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens have?

Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens has 1 U.S. trademark filed with the USPTO.

What trademark classes does Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens file in?

Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens files trademarks across 1 Nice Classification class. The most active classes are Class 41 (Education & Entertainment). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What is Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens's trademark registration success rate?

Cline Living Trust, comprising Craig A. Cline and Cherie E. Cline, both are US Citizens has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.